86.85 F
New York, US
June 15, 2026
PreetNama
English News

Trump wants to use oil crash to add 75 mn barrels to fill national stockpile

President Donald Trump said Monday the United States would take advantage of the historic drop in oil prices to replenish its national strategic stockpile, pending approval by Congress.

“We are filling up our national petroleum reserves… You know, the strategic reserves,” Trump told reporters at his daily coronavirus press conference.

“And we are looking to put as much as 75 million barrels into the reserves themselves,” he added.

Later in the briefing, he specified that he would only buy that amount if Congress authorized the funding — or if the federal government could rent storage space to third parties for a feWhen prices eventually rebound, these vendors could sell their excess oil.

US oil prices crashed to unprecedented lows Monday as futures in New York ended in negative territory for the first time amid a devastating supply glut that has forced traders to pay others to take the crude off their hands.

The president had announced his intention on March 13 to fill the Strategic Petroleum Reserve (SPR) to the brim.As of April 17, it contained 635 million barrels of its current authorized limit of 713.5 million barrels.

Stored in a complex of four underground sites along the Gulf coasts of Texas and Louisiana, in the south of the United States, the SPR has a total storage capacity of 727 million barrels.

This is intended for use in case of emergencies such as the 1991 Iraq War, or in 2005 after Hurricane Katrina.

Related posts

Air pollution linked to mental health issues in kids

On Punjab

Covid-19 update: ‘US is praying for you’ Melania Trump dials British PM Boris Johnson’s pregnant fiancée

On Punjab

he plans for AstraZeneca’s new headquarters and large R&D campus in Cambridge were unveiled in 2013, but its costs and timeframe have exceeded the initial estimate of 330 million pounds and an aimed completion date of 2016. AstraZeneca, which has a large portfolio of treatments for diseases such as cancer, heart disease and diabetes, said the centre would support research into specialised medicines and next-generation therapeutics, including gene-editing and cell therapies. “We will have advances that could come to the clinic in the next three, four years, that can lead to really effective new drugs in various aspects of treating cancer,” Dr Susan Galbraith, AstraZeneca’s executive vice president, Oncology Research & Development, told Reuters in an interview. “I’m very optimistic about the fact that we can make a big difference to this disease in the coming decade”.

On Punjab